Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Shugao Ye"'
Autor:
Yuan Chen, Jialong Liang, Qian Li, Jintao Zhou, Jian Xu, Dian Xiong, Huachi Jiang, Shugao Ye, Jingyu Chen
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary hypertension with a low incidence. Despite pulmonary endarterectomy(PEA) being the preferred treatment for CTEPH, for patients who failed medical therapy
Externí odkaz:
https://doaj.org/article/43e8d75c04174d84add11303ffe0d12f
Autor:
Jian Wang, Zhilong Zhang, Qian Li, Zilong Hu, Yuan Chen, Hao Chen, Wei Cai, Qiancheng Du, Peng Zhang, Dian Xiong, Shugao Ye
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Background: Curcumin (CUR), an effective traditional Chinese medicinal extract, displays good anti-cancer activity against various cancers. Nevertheless, the impacts and fundamental mechanisms of CUR to treat esophageal squamous cell carcinoma (ESCC)
Externí odkaz:
https://doaj.org/article/fcd38825fa0840ef8dd6e8e84ceac62e
Publikováno v:
Journal of Cardiothoracic Surgery, Vol 17, Iss 1, Pp 1-7 (2022)
Abstract Background Maternal mortality has always been a major medical concern. Recently, the successful application of extracorporeal membrane oxygenation (ECMO) technology in the rescue of near-death patients has been reported. Case presentation Th
Externí odkaz:
https://doaj.org/article/7d6c9b0cd78545bca974d17c1beb89d7
Autor:
Dian Xiong, Fei Gao, Jingbo Shao, Yueyun Pan, Song Wang, Dong Wei, Shugao Ye, Yuan Chen, Rui Chen, Bingqing Yue, Juan Li, Jingyu Chen
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Idiopathic pulmonary fibrosis is a severe and deadly form of diffuse parenchymal lung disease and treatment options are few. Alveolar epithelial type 2 (AEC2) cell senescence is implicated in the pathogenies of IPF. A major bioactive comp
Externí odkaz:
https://doaj.org/article/7593f17cbc604e32bbc81a6baa08624e
Autor:
Jiayue Yang, Cheng Yang, Hong Shen, Wenjun Wu, Zhen Tian, Qinghua Xu, Cuiping Cao, Shugao Ye, Le Ban, Xin Tong, Jie Mei
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-13 (2021)
Abstract Background Patients with type 2 diabetes mellitus (T2DM) have an increased risk of suffering from various malignancies. This study aimed to identify specific biomarkers that can detect lung adenocarcinoma (LAC) in T2DM patients for the early
Externí odkaz:
https://doaj.org/article/20d4156e46d44ca7ae407ccc77314bab
Autor:
Jialong Liang, Yuan Chen, Jintao Zhou, Mingfeng Zheng, Feng Liu, Shugao Ye, Jingyu Chen, Yong Ji
Publikováno v:
Frontiers in Surgery, Vol 9 (2022)
Pulmonary arteriovenous fistula (PAVF) is a rare pulmonary vascular lesion, more than 80% of which is caused by congenital abnormal development of pulmonary capillaries. The incidence of PAVF ranges from 2/100,000 to 3/100,000, with no difference in
Externí odkaz:
https://doaj.org/article/af7d66bc38a443a88a01c28ddd5ca4c7
Autor:
Dong Liu, Ji Zhang, Bo Wu, Feng Liu, Shugao Ye, Hongmei Wang, Jian Lv, Xing Weng, Yan Chen, Weili Han, Jingyu Chen
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background The effect of donor lung colonized bacteria on the prognosis of lung transplantation is not clear. We used the technique of next-generation sequencing (NGS) to detect the colonized bacteria from the lower respiratory tract and ana
Externí odkaz:
https://doaj.org/article/384224eeea2e40cd8d73113b287f1d93
Publikováno v:
Frontiers in Surgery, Vol 8 (2021)
Background: Destroyed lung can cause mediastinal displacement and asymmetric chest deformity. Reports on bilateral lung transplantation (LT) to treat destroyed lung and asymmetric chest deformity are rare. This study presents our surgical experience
Externí odkaz:
https://doaj.org/article/ecfe3a48866f4d039a6e69122cb7fe4a
Publikováno v:
Journal of Immunology Research, Vol 2021 (2021)
Background. Lung transplantation has been performed worldwide and admitted as an effective treatment for patients with various end-stage lung diseases. However, limit reliable clinical indicators exist to identify patients at high risk for allograft
Externí odkaz:
https://doaj.org/article/1c17e4ecd091436597347431884f68ef
Publikováno v:
Transplant Immunology. Jun2024, Vol. 84, p1-7. 7p.